Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema.

Human immunology - 1 Jun 2002

Freiberger Tomás, Vyskocilová Martina, Kolárová Lenka, Kuklínek Pavel, Krystůfková Olga, Lahodná Marie, Hanzlíková Jana, Litzman Jirí

Abstract excerpt

Polymorphic variants of B2 receptors for bradykinin (B2BKR) have been postulated to influence a clinical manifestation of hereditary angioedema. In this study, exon 1 nonanucleotide deletion polymorphism in the B2BKR gene was examined in 37 patients with hereditary angioedema. The patients were grouped according to disease severity or the age of the first clinical manifestation of disease. No significant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angioedema
Share to Czech Republic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Frequency

Share to Genotype

Share to Polymorphism, Genetic

Share to Receptor, Bradykinin B2

Share to White People

Source

Identifiers

PMID: 12039525
DOI: 10.1016/s0198-8859(02)00397-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Exon 1 polymorphism of the B2BKR gene does not influence the clinical status of patients with hereditary angioedema.PMID 12039525Read ↗

No evidence for linkage between the hereditary angiooedema clinical phenotype and the BDKR1, BDKR2, ACE or MBL2 gene.Semantic proximity Read ↗

Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N‐terminal cleavage site of bradykininSemantic proximity Read ↗

Analysis of an exon 1 polymorphism of the B2 bradykinin receptor gene and its transcript in normal subjects and patients with C1 inhibitor deficiency.Semantic proximity Read ↗

Common variants near the bradykinin receptor B<sub>2</sub>gene are associated with angioedema induced by angiotensin-converting-enzyme inhibitor treatment - a genome wide association studySemantic proximity Read ↗

Association of Variants Near the Bradykinin Receptor B2 Gene With Angioedema in Patients Taking ACE Inhibitors.Semantic proximity Read ↗

Sequence variation of bradykinin receptors B1 and B2 and association with hypertension.Semantic proximity Read ↗

Genetic Determinants of C1 Inhibitor Deficiency Angioedema Age of Onset.Semantic proximity Read ↗

Polymorphisms in the gene for the human B2-bradykinin receptor. New tools in assessing a genetic risk for bradykinin-associated diseases.Semantic proximity Read ↗

Identification of polymorphic sites of the human bradykinin B2 receptor gene.Semantic proximity Read ↗

Characterization of two polymorphic sites in the human kinin B1 receptor gene: altered frequency of an allele in patients with a history of end-stage renal failure.Semantic proximity Read ↗

A novel sequence polymorphism in the promoter region of the human B2-bradykinin receptor gene.Semantic proximity Read ↗

Lack of association between HLA class II polymorphisms and essential hypertension in a Belgian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.